These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 23389975

  • 1. [Protective effects of snake venom antimicrobial peptide OH-CATH on E. coli induced rabbit urinary tract infection models].
    Zhang BY, Li SM, Gao ZH, Shen JH.
    Dongwuxue Yanjiu; 2013 Feb; 34(1):27-32. PubMed ID: 23389975
    [Abstract] [Full Text] [Related]

  • 2. Susceptibility of Escherichia coli strains isolated from outpatient children with community-acquired urinary tract infection in southern Switzerland.
    Borsari AG, Bucher B, Brazzola P, Simonetti GD, Dolina M, Bianchetti MG.
    Clin Ther; 2008 Nov; 30(11):2090-5. PubMed ID: 19108796
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Comparative in-vitro activity of cefoperazone-tazobactam and cefoperazone-sulbactam combinations against ESBL pathogens in respiratory and urinary infections.
    Patankar M, Sukumaran S, Chhibba A, Nayak U, Sequeira L.
    J Assoc Physicians India; 2012 Nov; 60():22-4. PubMed ID: 23767198
    [Abstract] [Full Text] [Related]

  • 7. Antibiotics susceptibility patterns of uropathogenic E. coli with special reference to fluoroquinolones in different age and gender groups.
    Ali I, Shabbir M, Noor Ul ImanDepartment of Medicine, Khyber Teaching Hospital Peshawar, Pakistan..
    J Pak Med Assoc; 2017 Aug; 67(8):1161-1165. PubMed ID: 28839298
    [Abstract] [Full Text] [Related]

  • 8. Intravesical hyaluronic acid and chondroitin sulfate alone and in combination for urinary tract infection: assessment of protective effects in a rat model.
    Tasdemir S, Tasdemir C, Vardi N, Yakupogullari Y, Duman Y, Parlakpinar H, Sagir M, Acet A.
    Int J Urol; 2012 Dec; 19(12):1108-12. PubMed ID: 22852837
    [Abstract] [Full Text] [Related]

  • 9. In vitro and in vivo activity of an antibacterial peptide analog against uropathogens.
    Cudic M, Lockatell CV, Johnson DE, Otvos L.
    Peptides; 2003 Jun; 24(6):807-20. PubMed ID: 12948832
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Impact of low-level fluoroquinolone resistance genes qnrA1, qnrB19 and qnrS1 on ciprofloxacin treatment of isogenic Escherichia coli strains in a murine urinary tract infection model.
    Jakobsen L, Cattoir V, Jensen KS, Hammerum AM, Nordmann P, Frimodt-Møller N.
    J Antimicrob Chemother; 2012 Oct; 67(10):2438-44. PubMed ID: 22685162
    [Abstract] [Full Text] [Related]

  • 12. Tazobactam-piperacillin compared with sulbactam-ampicillin, clavulanic acid-ticarcillin, sulbactam-cefoperazone, and piperacillin for activity against beta-lactamase-producing bacteria isolated from patients with complicated urinary tract infections.
    Nomura S, Hanaki H, Nagayama A.
    J Chemother; 1997 Apr; 9(2):89-94. PubMed ID: 9176745
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Trends in antimicrobial susceptibility of Escherichia coli isolates from urology services in The Netherlands (1998-2005).
    Nys S, Terporten PH, Hoogkamp-Korstanje JA, Stobberingh EE, Susceptibility Surveillance Study Group.
    J Antimicrob Chemother; 2008 Jul; 62(1):126-32. PubMed ID: 18417487
    [Abstract] [Full Text] [Related]

  • 17. Temporal changes in the prevalence of community-acquired antimicrobial-resistant urinary tract infection affected by Escherichia coli clonal group composition.
    Smith SP, Manges AR, Riley LW.
    Clin Infect Dis; 2008 Mar 01; 46(5):689-95. PubMed ID: 18230040
    [Abstract] [Full Text] [Related]

  • 18. In vitro activity of cefoperazone-sulbactam: Singapore experience.
    Kumarasinghe G, Chow C, Chiu C, Cheong YM.
    Southeast Asian J Trop Med Public Health; 1996 Dec 01; 27(4):734-7. PubMed ID: 9253876
    [Abstract] [Full Text] [Related]

  • 19. Human lactoferrin and peptides derived from a surface-exposed helical region reduce experimental Escherichia coli urinary tract infection in mice.
    Håversen LA, Engberg I, Baltzer L, Dolphin G, Hanson LA, Mattsby-Baltzer I.
    Infect Immun; 2000 Oct 01; 68(10):5816-23. PubMed ID: 10992490
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.